All | SCR | SCR + TAR | p-value | COMP | p-value | COMP+TAR | p-value | AVS | p-value | |
---|---|---|---|---|---|---|---|---|---|---|
Cohort number | 407 | 141 (35) | 75 (18) | – | 119 (29) | – | 27 (7) | – | 29 (7) | – |
Gender, male | 285 (70) | 87 (61) | 52 (69) | 0.224 | 89 (75) | 0.018 | 21 (78) | 0.097 | 24 (82) | 0.025 |
Age (years) | 58 ± 13 | 61 ± 13 | 58 ± 11 | 0.162 | 56 ± 14 | 0.017 | 51 ± 13 | 0.001 | 58 ± 11 | 0.304 |
Marfan syndrome | 15 (3.7) | 4 (3) | 4 (5) | 0.417 | 5 (4) | 0.587 | 1 (4) | 0.816 | 0 (0) | 0.345 |
DeBakey type 2a | 123 (30) | 49 (35) | 0 (0) | < 0.001 | 50 (42) | 0.160 | 13 (48) | 0.520 | 9 (31) | 0.927 |
Bicuspid aortic valve | 21 (5.2) | 5 (4) | 5 (7) | 0.336 | 3 (3) | 0.603 | 3 (12) | 0.089 | 3 (11) | 0.130 |
Previous surgery | 49 (12) | 20 (14) | 9 (12) | 0.568 | 16 (14) | 0.728 | 1 (4) | 0.160 | 1 (3) | 0.088 |
Pericardial effusion | 120 (30) | 38 (27) | 25 (33) | 0.342 | 34 (29) | 0.766 | 6 (22) | 0.067 | 12 (41) | 0.126 |
Resuscitation | 22 (5.4) | 8 (6) | 0 (0) | 0.036 | 10 (8) | 0.388 | 2 (11) | 0.067 | 1 (4) | 0.626 |
Shock | 63 (16) | 18 (13) | 7 (9) | 0.301 | 27 (23) | 0. 032 | 4 (15) | 0.068 | 5 (18) | 0.473 |
General malperfusion | 80 (20) | 35 (26) | 10 (14) | 0.042 | 24 (21) | 0.448 | 2 (8) | 0.065 | 7 (25) | 0.950 |
Coronary malperfusion | 42 (10.3) | 19 (14) | 5 (7) | 0.101 | 11 (10) | 0.267 | 2 (8) | 0.424 | 2 (7) | 0.302 |
New neurological symptoms | 57 (14) | 17 (12) | 15 (20) | 0.123 | 12 (10) | 0.601 | 8 (31) | 0.003 | 2 (7) | 0.416 |